SCHEMBL6258346

SCHEMBL6258346

CNc1nc2cc([N+](=O)[O-])ccc2n1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
RAB9A P51151 2/20 0.50
MAPK1 P28482 2/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
MAP3K7 O43318 1/20 0.48
IRAK1 P51617 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
APOBEC3G Q9HC16 2/20 0.47
MPI P34949 1/20 0.47
FGFR1 P11362 1/20 0.46
HTT P42858 2/20 0.45
PKM P14618 2/20 0.45
KDM4E B2RXH2 1/20 0.45
APOBEC3A P31941 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209281 0.81 ALDH1A1 (0.54) ALDH1A1RAB9AMEN1KMT2ALMNA
SCHEMBL6234925 0.80 ALDH1A1 (0.56) ALDH1A1RAB9AMAPK1MEN1KMT2A
SCHEMBL5097405 0.78 IRAK4 (0.58) ALDH1A1RAB9AMAPTSMN1; SMN2NPC1
SCHEMBL28561369 0.78 ALDH1A1 (0.50) ALDH1A1RAB9AMAPK1MEN1KMT2A
SCHEMBL4979124 0.76 IRAK4 (0.53) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL4976756 0.75 HDAC6 (0.57) ALDH1A1RAB9AMEN1KMT2ALMNA
SCHEMBL6582029 0.75 MEN1 (0.55) ALDH1A1MEN1KMT2A
SCHEMBL6582022 0.75 MEN1 (0.55) ALDH1A1MEN1KMT2A
SCHEMBL8027350 0.74 ALDH1A1 (0.60) ALDH1A1RAB9AMAPK1MEN1KMT2A
SCHEMBL29116234 0.74 ALDH1A1 (0.52) ALDH1A1RAB9AMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004092181-A9 HETEROCYCLIC MCHR1 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2005-01-27 WO disclosed